BioStem Technologies, Inc. (BSEM)
2.73
-0.34
(-11.07%)
USD |
NASDAQ |
Oct 02, 16:00
2.73
0.00 (0.00%)
After-Hours: 20:00
BioStem Technologies Profit Margin (Quarterly) : -113.6% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -113.6% |
| March 31, 2026 | -143.7% |
| December 31, 2025 | -111.7% |
| September 30, 2025 | 7.27% |
| June 30, 2025 | 0.10% |
| March 31, 2025 | 24.48% |
| December 31, 2024 | 64.78% |
| September 30, 2024 | 37.04% |
| June 30, 2024 | 8.44% |
| March 31, 2024 | 7.77% |
| December 31, 2023 | -23.96% |
| September 30, 2023 | -43.95% |
| June 30, 2023 | -267.2% |
| March 31, 2023 | -621.4% |
| December 31, 2022 | -475.4% |
| September 30, 2022 | -77.48% |
| June 30, 2022 | 15.01% |
| March 31, 2022 | -99.59% |
| December 31, 2021 | -23.54% |
| September 30, 2021 | -38.23% |
| Date | Value |
|---|---|
| June 30, 2021 | -40.13% |
| March 31, 2021 | -14.68% |
| December 31, 2020 | -57.08% |
| September 30, 2020 | -155.0% |
| June 30, 2020 | -293.0% |
| March 31, 2020 | -50.19% |
| June 30, 2019 | -296.1% |
| March 31, 2019 | -450.4% |
| December 31, 2018 | -701.9% |
| September 30, 2018 | -457.8% |
| June 30, 2018 | -2.47K% |
| March 31, 2018 | -2.10K% |
| December 31, 2017 | -656.8% |
| September 30, 2017 | -2.88K% |
| June 30, 2017 | -1.92K% |
| March 31, 2017 | -231.7% |
| December 31, 2016 | -523.7% |
| September 30, 2016 | -1.02K% |
| June 30, 2016 | -1.02K% |
| March 31, 2016 | -333.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Wave Life Sciences, Inc. | -3.05K% |
| Axsome Therapeutics, Inc. | -23.50% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -71.90% |
| Return on Assets | -42.98% |
| Return on Invested Capital | -66.87% |
| Gross Profit Margin (Quarterly) | 52.55% |
| Operating Margin (Quarterly) | -106.3% |
| Return on Net Operating Assets | -64.56% |